Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
BROMODOMAIN AND EXTRA-TERMINAL PROTEIN INHIBITOR COMBINATION THERAPY

No-Receipt date 2022-01021 - 17/03/2022
No-Filing date 20220400616 - 17/03/2022
No-Granting date 3109955 - 23/03/2022
No-EPO application date 17864117.1 - 26/10/2017
No-EPO granting date 3532059 - 26/01/2022
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 3/2022 - 18/04/2022
Expiration date 27/10/2037
Kind of title Validation of European Patent
Legal status VALID
Priorities US201662413763 P27/10/2016/US
US201762560840 P20/09/2017/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61P 35/00
A61K 9/00
A61K 45/06
A61K 38/15
A61K 31/495
A61K 31/472
A61K 31/337

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1402580 CELGENE QUANTICEL RESEARCH, INC. 9393 TOWNE CENTRE DRIVESAN DIEGO, CA 92129 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
3612736 CHO, ROBERT
3612737 STAFFORD, JEFFREY ALAN

Representatives
CodeFirstnameSurnameAddressTownZip
3712ANTHOULAGALANOPOULOUTHESI LYSI MPITAKOUKAPANDRITI (ATTIKIS)19014

Contact
CodeFirstnameSurnameAddressTownZipCountry
9219ALKISTIS-EIRINIMALAMIVISSARIONOS 3ATHINA (ATTIKIS)10672 GREECE

Owners History

Title Instruments

Payments history 8 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015